Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Transmission and prevention news

Show

From To
UK Government appoints first National Adviser for LGBT Health

Clinical adviser in the NHS appointed to advise on LGBT health issues. Expert panel also appointed, which will focus on key issues such as conversion therapy, improving access and tackling inequality in healthcare.

Published
18 March 2019
From
gov.uk
LGBT+ health adviser urges Britain to make HIV-prevention drug free

Britain’s first national adviser for LGBT+ health has said the roll-out of a highly effective HIV prevention pill could save hundreds of thousands of pounds for the country’s publicly funded health authority. In an exclusive interview Michael Brady, who will take up the role on April 1, said a planned roll-out of pre-exposure prophylaxis (PrEP) - a once-daily pill that protects against HIV – in England would prove cost effective “very quickly”.

Published
18 March 2019
From
Reuters
Promises to improve health outcomes for people who inject drugs remain unfulfilled as 99% do not have adequate access to HIV and harm reduction services

New report by UNAIDS highlights the urgent need to implement a human rights and evidence-informed approach to reach people who inject drugs with essential health services.

Published
13 March 2019
From
UNAIDS
Dramatic rise in U.S. opioid deaths as epidemic spreads to eastern states

Long believed to be concentrated among Appalachian states and parts of the Midwest, Alexander's research shows that the crisis has spread. Eastern states have seen a sharp rise in opioid deaths – with Connecticut, Illinois, Indiana, Massachusetts, Maryland, Maine, New Hampshire and Ohio among the states with the highest rise in opioid-related deaths.

Published
13 March 2019
From
Medical Xpress
HIV antibody VRC01LS safe prevention strategy for infants

Subcutaneous doses of a broadly neutralizing monoclonal antibody, known as VRC01LS, given at birth and 12 weeks were well-tolerated by HIV-exposed infants, according to the results of an open-label safety and pharmacokinetic study presented at the Conference on Retroviruses and Opportunistic Infections. Researchers are studying VRC01LS in combination with ART to prevent HIV infection in neonates.

Published
12 March 2019
From
Healio
Largest ever HIV prevention study delivers sobering message

The recipe for ending HIV epidemics seems straightforward. Introduce widespread testing. Immediately put those who test positive on antiretroviral (ARV) drugs, which suppress the virus to undetectable levels so those people won’t infect others. The number of new infections will drop, and the epidemic will peter out. But massive, costly studies done in the past few years have failed to show this strategy can reliably curb the spread of the virus, to the frustration of researchers.

Published
12 March 2019
From
Science
Effective HIV Interventions Have Changed the Approach to Trials

In the past, individuals who were at high risk for HIV infection and who were enrolled in placebo-controlled prevention trials had been typically randomly assigned to either an experimental agent or placebo. However, that trial design—and the way those trials were interpreted—has shifted. This was the topic of discussion during David Dunn’s session yesterday at the Conference on Retroviruses and Opportunistic Infections (CROI) 2019. Dunn is a researcher at University College London in the United Kingdom.

Published
11 March 2019
From
Infectious Diseases Consultant
CROI 2019: Thailand’s strides spanned HIV treatment, prevention and research

he first HIV vaccine trials to yield signs of hope happened here. Thailand was also the first Asian country to eliminate mother-to-child transmission of HIV. Now, Thailand has achieved the first part of UNAIDS’ 90-90-90 targets: 98 percent of people infected with HIV know their status.

Published
06 March 2019
From
Science Speaks
Study to investigate how sexual trauma increases HIV susceptibility in women

Novel study to investigate how sexual trauma increases HIV susceptibility in women.

Published
05 March 2019
From
Eurekalert Inf Dis
Molecular data helps identify HIV networks

Using molecular data to supplement information gained through public health interviews — chiefly, the names of sexual or needle-sharing partners — can help identify HIV transmission networks and prevent new infections in states with low HIV morbidity, researchers reported in a recent MMWR.

Published
05 March 2019
From
Healio
← First12345...367Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.